Actively Recruiting
Computer-assisted Cognitive Stimulation Treatment for Delirium
Led by Institut Investigacio Sanitaria Pere Virgili · Updated on 2026-05-01
60
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
I
Institut Investigacio Sanitaria Pere Virgili
Lead Sponsor
I
Institut Pere Mata
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objectives of our study are to determine whether people with delirium in a subacute care unit improve after one week with non-pharmacological therapies based on improving sleep schedules, mobility, and cognitive stimulation (such as memory, attention, orientation, among others), and to compare two groups of people who will receive slightly different therapies. We will try to determine whether individual characteristics (such as diagnosed diseases, blood test results or genetics, gender, age, educational level, among others) influence the onset of an episode of delirium, its severity and its response to treatment. Participants with delirium will be divided into two groups that will receive: * The non-pharmacological treatment described * One group will also receive a specific cognitive intervention from an occupational therapist, using a computer programme on a tablet, twice a day for one week. After one week, the presence and severity of delirium will be reassessed.
CONDITIONS
Official Title
Computer-assisted Cognitive Stimulation Treatment for Delirium
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 60 years or older
- Admitted to the subacute care center between 15 February and 15 October 2026
- Signed informed consent by the patient or legal guardian if the patient cannot consent
You will not qualify if you...
- Receiving palliative end-of-life care at admission
- Under 60 years of age
- Severe visual or hearing impairment or aphasia
- Serious communication difficulties due to language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut Pere Mata
Reus, Tarragona, Spain, 43206
Actively Recruiting
Research Team
E
Esteban Sepulveda-Ramos, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here